AN2 Therapeutics Inc.
(ANTX)
undefined
undefined%
At close: undefined
1.38
-0.36%
After-hours Jan 06, 2025, 04:51 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -64.73M | -40.96M | -21.54M | -13.60M | -5.63M |
| Depreciation & Amortization | n/a | -692.00K | n/a | n/a | n/a |
| Stock-Based Compensation | 8.41M | 4.39M | 974.00K | 40.00K | n/a |
| Other Working Capital | 5.28M | 1.22M | -385.00K | 1.14M | 6.00K |
| Other Non-Cash Items | -2.80M | 77.00K | 53.00K | 6.97M | 3.17M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 5.83M | 3.72M | 32.00K | 1.22M | -10.00K |
| Operating Cash Flow | -53.29M | -33.46M | -20.48M | -5.36M | -2.49M |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -132.18M | -93.84M | -77.27M | n/a | n/a |
| Sales Maturities Of Investments | 88.90M | 72.06M | 27.25M | n/a | n/a |
| Other Investing Acitivies | n/a | -21.77K | -50.02K | n/a | n/a |
| Investing Cash Flow | -43.28M | -21.77M | -50.02M | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | -11.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 465.00K | -11.00K | 78.53M | 3.84M | 48.50M |
| Financial Cash Flow | 84.99M | 70.36M | 78.53M | 3.84M | 8.08M |
| Net Cash Flow | -11.57M | 15.12M | 8.03M | -1.53M | 5.60M |
| Free Cash Flow | -53.29M | -33.46M | -20.48M | -5.36M | -2.49M |